New investment helps to ensure patients can access high-quality and reproducible testing across labs worldwide NEW YORK, June 2, 2025 /PRNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) today announced an investment of up to $2M to expand a quality control program for blood...
Read More Details
Finally We wish PressBee provided you with enough information of ( The Alzheimer's Drug Discovery Foundation's Diagnostics Accelerator (DxA) Invests in Expansion of Quality Control Program for Blood and CSF Biomarkers )
Also on site :
- 'American Pickers' Mike Wolfe's New Career Move Has a Surprising Connection to Danielle Colby
- A hot trend in the housing market is Gen Z buying homes with siblings
- Beloved Country Star, 65, Joined by Son in First Performance Since Husband's Death